Market Value1,354,085,000
Total Holdings49
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VINC / Vincerx Pharma, Inc.
KLDO / Kaleido Biosciences, Inc.
PLRX / Pliant Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc.
STRO / Sutro Biopharma, Inc.
VSTM / Verastem, Inc.
GMXAY / Genmab A/S
ZYME / Zymeworks Inc.
US74140Y1010 / Prevail Therapeutics Inc.
GERN / Geron Corporation
ANAB / AnaptysBio, Inc.
MORF / Morphic Holding, Inc.
NLTX / Neoleukin Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc.
AMTI / Applied Molecular Transport Inc.
CRSP / CRISPR Therapeutics AG
DRNA / Dicerna Pharmaceuticals Inc
FGEN / FibroGen, Inc.
BCEL / Atreca, Inc.
IPHA / Innate Pharma S.A. - Depositary Receipt (Common Stock)
EVLO / Evelo Biosciences, Inc.
XCUR / Exicure, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
US2103731061 / Constellation Pharmaceuticals Inc Call
EQ / Equillium, Inc.
FULC / Fulcrum Therapeutics, Inc.
ICPT / Intercept Pharmaceuticals Inc Call
ZIOP / Alaunos Therapeutics Inc
VIR / Vir Biotechnology, Inc.
FOLD / Amicus Therapeutics, Inc.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
RARE / Ultragenyx Pharmaceutical Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
IRWD / Ironwood Pharmaceuticals, Inc. Call
MRUS / Merus N.V.
XOMA / XOMA Royalty Corporation
IONS / Ionis Pharmaceuticals, Inc.
PBYI / Puma Biotechnology, Inc.
RPRX / Royalty Pharma plc
US33830X1046 / Five Prime Therapeutics Inc
CTMX / CytomX Therapeutics, Inc.
CRVS / Corvus Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
RGLS / Regulus Therapeutics Inc.
US2103731061 / Constellation Pharmaceuticals Inc
KURA / Kura Oncology, Inc.
SURF / Surface Oncology Inc
AKUS / Akouos Inc
MGTX / MeiraGTx Holdings plc
RCUS / Arcus Biosciences, Inc.
TRIL / Trillium Therapeutics Inc
SVRA / Savara Inc.
MGTA / Magenta Therapeutics Inc
PRTA / Prothena Corporation plc
ASMB / Assembly Biosciences, Inc.
RPTX / Repare Therapeutics Inc.
ACRS / Aclaris Therapeutics, Inc.
US16706W1027 / Chiasma Inc
GLYC / GlycoMimetics, Inc.
DNLI / Denali Therapeutics Inc.
SELB / Selecta Biosciences Inc
EXEL / Exelixis, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
FATE / Fate Therapeutics, Inc.
ARVN / Arvinas, Inc.
CYCN / Cyclerion Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
RNA / Avidity Biosciences, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
KROS / Keros Therapeutics, Inc.
XNCR / Xencor, Inc.